Johnson & Johnson

Investor type

CVC

Founded

1887

AUM

$180 000 M

Location

Cambridge, Massachusetts, United States

Investment Ticket

$0-1 m

Investment Stage

Seed Series A

Region of investment

North America Europe

ESG Focus

Impact investor
Investor profile last updated: 16 August, 2026

Profile

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.

Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.

At Johnson & Johnson, we blend heart, science and ingenuity to profoundly change the trajectory of health for humanity. We aspire to positively impact patients, consumers and all others we serve with our life-saving medicines, products and devices, as well as the health of our employees, our communities and the planet. We seek to provide solutions for some of the world’s most pressing global public health challenges and work collectively—within our walls and externally with partners—to advance better health for all.


Enterprise, Social and Governance (ESG) Investors Update Webcast
At Johnson & Johnson, our sustainability approach means generating social, environmental and economic value for all of Our Credo stakeholders: patients, consumers, healthcare providers and all others we serve, employees, the communities in which we live and work, business partners, investors and society as a whole.

Our Health for Humanity 2025 Goals focus our citizenship and sustainability efforts where we believe Johnson & Johnson can achieve the greatest impact.

Industry

Fashion/Beauty Food and Beverage Foodtech Healthcare Services Media and Entertainment Other Robotics Software Consumer Products Consumer Services (B2C) Medical Devices Pharmaceuticals MedTech

Johnson & Johnson Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Johnson & Johnson Innovation – JJDC, Inc.
Corporate VC (CVC)
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
Pharmaceuticals
MedTech
Seed
Series A
Series B
Late Stage (Series C+)
North America
Europe
Asia
$5-10 m
$978 M
June 1973

Contacts

Name
Title
Email
avatar
Jason Haviland Senior Director Oncology, Global Strategic Analytics
Senior Director Oncology, Global Strategic Analytics
j•••@•••
avatar
Prashant Dubey Senior Manager, Big Data Services
Senior Manager, Big Data Services
p•••@•••
Upgrade to see contacts
avatar
dbz3UkGQiqZD2FAM dbz3UkGQiqZD2FAM
dbz3UkGQiqZD2FAM
avatar
dbz3UkGQiqZD2FAM dbz3UkGQiqZD2FAM
dbz3UkGQiqZD2FAM
avatar
dbz3UkGQiqZD2FAM dbz3UkGQiqZD2FAM
dbz3UkGQiqZD2FAM
Investment-team contacts for Johnson & Johnson — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Johnson & Johnson

Johnson & Johnson operates as a corporate VC (CVC). It backs companies at Seed and Series A, writing tickets of $0-1 m.
Johnson & Johnson is located in Cambridge, Massachusetts, United States.
Johnson & Johnson was founded in 1887.
Johnson & Johnson invests in companies and startups in Fashion/Beauty, Food and Beverage, Foodtech, Healthcare Services, Media and Entertainment, Other, Robotics, Software, Consumer Products, Consumer Services (B2C), Medical Devices, Pharmaceuticals, MedTech.
Johnson & Johnson invests in companies and startups in North America, Europe.
Johnson & Johnson invests in companies and startups at Seed, Series A.
Johnson & Johnson usually invests $0-1 m on average.
Johnson & Johnson has around $180 000m assets under management.
Johnson & Johnson last fund was created/launched in 1973-06-01
Yes, Johnson & Johnson is impact investor.
Johnson & Johnson can be reached through its website jnjinnovation.com/home, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Johnson & Johnson — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Johnson & Johnson directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.